Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Colorectal Neoplasms 4Triple Negative Breast Neoplasms 3Pancreatic Neoplasms 2Breast Neoplasms 2Recurrence 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Ovarian Cancer Recurrent 1Neoplasm Metastasis 1Melanoma 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1

Interventions

Paclitaxel 24Hyperthermic Intraperitoneal Chemotherapy 24Cisplatin 22Oxaliplatin 17Carboplatin 17Fluorouracil 13Cytoreduction Surgical Procedures 13Bevacizumab 10Mitomycin 9Leucovorin 8Doxorubicin 8Docetaxel 6Gemcitabine 5130-nm albumin-bound paclitaxel 5Surgical Procedures, Operative 4Blood Specimen Collection 4Albumin-Bound Paclitaxel 4sodium thiosulfate 3liposomal doxorubicin 3catumaxomab 3Taxes 3Neoadjuvant Therapy 3Laparoscopy 3Drug Therapy 3tremelimumab 2relacorilant 2pembrolizumab 2olaparib 2nintedanib 2epothilone B 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Peritoneal Neoplasms × poly(I).poly(c12,U) × Clear all
NCT02151448 2020-07-20

αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies

University of Pittsburgh

Phase 1/2 Completed
64 enrolled 18 charts
Gynecologic

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡